Rewat 3.35 gm/5 ml (Oral Solution)
100 ml bottle: ৳ 120.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Lactulose |
| Company | Kumudini pharma ltd |
Title
- Rewat 3.35 gm/5 ml Oral Solution
Categories
- Medicine
- Laxative
- Hyperosmolar Laxative
Description
- Hyperosmolar laxative
- Effective treatment for constipation
- Non-absorbable disaccharide
- Draws water into the bowel
- Causes distention through fluid accumulation
- Promotes soft stool
- Accelerates bowel motion
Indications
- Chronic constipation
- Diet rich in fiber
- Generous amount of liquids
- Physical exercise
- Intestinal flora disturbances
- Increased blood ammonia levels
- Hyper ammoniemia in hepatopathy
- Portal-systemic encephalopathy
Pharmacology
- Synthetic disaccharide
- Metabolized in the colon by saccharolytic bacteria
- Produces low molecular weight organic acids
- Lowers the pH of the colon contents
- Promotes the retention of water by an osmotic effect
- Increases peristaltic activity
- Minimally absorbed
Dosage & Administration
- Adult dosage
- Children dosage
- Infants and toddlers dosage
- Dosage in damaged intestinal flora
- Dosage for reduction of blood ammonia level
- Maximum dosage for hyper-ammoniemia in hepatopathy
- Dose reduction in portal systemic encephalopathy
Interaction
- No significant drug interactions with Rewat
- Potassium deficiency intensifies glycosidic effect of cardiac glycosides
Contraindications
- Hypersensitivity to galactose and lactose
- Galactose-free diet
- Gastro-cardial symptom complex
- Suspected intestinal obstruction
Side Effects
- Flatulence
- Cramp
- Abdominal discomfort
- Rapidly eliminated by reducing the dose
- Overdose resulting in diarrhea
- Loss of electrolytes, primarily potassium
Pregnancy & Lactation
- US FDA Pregnancy Category B
- No adverse effects shown in studies
- Decisions regarding use during pregnancy and lactation must be made by registered physician
Precautions & Warnings
- Administered with care to patients intolerant to Rewat
- Higher dose in (pre) coma hepaticum
Overdose Effects
- No reports of accidental overdosage
- Expected symptoms: diarrhea and abdominal cramps
Therapeutic Class
- Osmotic purgatives
Storage Conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C12H22O11
- Chemical Structure Image
Commonly Asked Questions
- Use of Rewat 3.35 gm/5 ml Solution
- Frequency of use
- Time taken for it to work
- Usage for constipation
- Nature of Solution
- Side effects
- Daily usage time
- Suitability for patients
- Effect of overdose
Image
- Chemical structure image URL
Related Brands
- Serelose 3.35 gm/5 ml (Oral Solution) - beximco-pharmaceuticals-ltd
- Sinalac 3.35 gm/5 ml (Oral Solution) - ibn-sina-pharmaceuticals-ltd
- Sivolac 3.35 gm/5 ml (Oral Solution) - sharif-pharmaceuticals-ltd
- Tulac 3.35 gm/5 ml (Oral Solution) - eskayef-pharmaceuticals-ltd
- Tulos 3.35 gm/5 ml (Oral Solution) - acme-laboratories-ltd